We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Smart Nanoparticles Designed to Identify, Target, and Kill Cancer Cells

By LabMedica International staff writers
Posted on 07 Apr 2010
Nanoparticles have been designed that can identify, target, and destroy specific cancer cells while leaving healthy cells alone.

Led by Dr. More...
Carl Batt, a professor of food science at Cornell University (Ithaca, NY, USA), the researchers synthesized nanoparticles--shaped similar to a dumbbell --made of gold sandwiched between two pieces of iron oxide. They then attached antibodies, which target a molecule found only in colorectal cancer cells, to the particles. Once bound, the nanoparticles are engulfed by the cancer cells.

To kill the cells, the researchers used a near-infrared laser, which is a wavelength that does not harm normal tissue at the levels utilized, but the radiation is absorbed by the gold in the nanoparticles. This causes the cancer cells to heat up and die. "This is a so-called ‘smart' therapy,” Dr. Batt said. "To be a smart therapy, it should be targeted, and it should have some ability to be activated only when it's there and then kills just the cancer cells.”

The goal, according to lead author and biomedical graduate student Dickson Kirui, is to improve the technology and make it suitable for testing in a human clinical trial. The researchers are now working on a similar experiment targeting prostate cancer cells. "If, down the line, you could clinically just target the cancer cells, you could then spare the health surrounding cells from being harmed--that is the critical thing,” Mr. Kirui said.

Gold has potential as a material key to combating cancer in future smart therapies. It is biocompatible, inert, and comparatively easy to modify chemically. By changing the size and shape of the gold particle, the investigators can tune them to respond to different wavelengths of energy.

Once taken up by the researchers' gold particles, the cancer cells are destroyed by heat--just a few degrees above normal body temperature--while the surrounding tissue is left unharmed. Such a low-power laser does not have any effect on surrounding cells because that specific wavelength does not heat up cells if they are not loaded up with nanoparticles, the researchers explained.

Using iron oxide, which is essentially rust, as the other parts of the particles might one day allow scientists to also track the progress of cancer treatments using magnetic resonance imaging, Mr. Kirui noted, by taking advantage of the particles' magnetic properties.

The research was published in the February 15, 2010, online edition of the journal Nanotechnology.

Related Links:

Cornell University




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.